Ana
del Pozo Rodríguez
Instituto de Investigación Sanitaria Bioaraba
Gasteiz, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Bioaraba (9)
2024
-
Gene therapy with lipid nanoparticles for Fabry disease: Leveraging E-selectin for targeted delivery to endothelial cells
Journal of Drug Delivery Science and Technology, Vol. 99
-
Population pharmacokinetics of oral fosfomycin calcium in healthy women
Journal of Antimicrobial Chemotherapy, Vol. 79, Núm. 11, pp. 2837-2845
-
Systematic Review of Genetic Substrate Reduction Therapy in Lysosomal Storage Diseases: Opportunities, Challenges and Delivery Systems
BioDrugs, Vol. 38, Núm. 5, pp. 657-680
-
Targeting strategies with lipid vectors for nucleic acid supplementation therapy in Fabry disease: a systematic review
Drug Delivery and Translational Research, Vol. 14, Núm. 10, pp. 2615-2628
2023
-
Novel Golden Lipid Nanoparticles with Small Interference Ribonucleic Acid for Substrate Reduction Therapy in Fabry Disease
Pharmaceutics, Vol. 15, Núm. 7
-
Pharmacokinetic/Pharmacodynamic Analysis of Oral Calcium Fosfomycin: Are Urine Levels Sufficient to Ensure Efficacy for Urinary Tract Infections?
Pharmaceutics, Vol. 15, Núm. 4
2022
-
Galactomannan-Decorated Lipidic Nanocarrier for Gene Supplementation Therapy in Fabry Disease
Nanomaterials, Vol. 12, Núm. 14
-
Supply of pharmaceutical care services: The key to a new model of health services
Atencion Primaria, Vol. 54, Núm. 1
-
mRNA delivery technologies: Toward clinical translation
International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 207-293